MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.6650
-0.0518 (-7.23%)
Mar 27, 2026, 12:00 PM EDT - Market open
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $71.06 million as of March 27, 2026. Its market cap has decreased by -78.92% in one year.
Market Cap
71.06M
Enterprise Value
-8.50M
1-Year Change
-78.92%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $71.06M, a decrease of -85.63%. That is a compound annual growth rate of -31.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 76.60M | -53.67% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
| Mar 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuronetics | 92.14M |
| Treace Medical Concepts | 82.68M |
| InspireMD | 80.97M |
| Xtant Medical Holdings | 79.26M |
| Sera Prognostics | 77.90M |
| QT Imaging Holdings | 75.87M |
| Baird Medical Investment Holdings | 74.55M |
| Picard Medical | 74.44M |